HIGHLIGHTS
- who: Benfotiamine et al. from the National Institute of Diabetes and endocrinology (NIDE), Nuclear Factor kappaB (NF-u03baB), Per Protocol (PP), Protein Kinase C (PKC), Research and have published the paper: Oral Benfotiamine 300 mg Versus Intramuscular Thiamine in Diabetic Patients with Peripheral Neuropathy, in the Journal: (JOURNAL)
- what: This study showed that the mean blood levels of Vitamin B1 were markedly increased after 2.5 hours in group A and amp; B who received oral Benfotiamine, while mildly increased in group C who received intramuscular thiamine) with statistically significant difference between the three treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.